CNXU
NASDAQ HealthcareConexeu Sciences Inc. - Common Stock
Biotechnology
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.
�� 市场数据
| 价格 | $16.84 |
|---|---|
| 成交量 | 287,648 |
| 52周最高 | $17.50 |
| 52周最低 | $10.87 |
| Price / Book | 48.95 |
🎯 投资策略评分
CNXU 在各投资策略中的评分。分数越高，越符合该策略目标。
在文本中查找 CNXU in your text
粘贴任何文章、记录或帖子 — 工具将提取 CNXU 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-06-02.